Adagio Medical Holdings (ADGM) Change in Accured Expenses (2023 - 2026)
Adagio Medical Holdings (ADGM) reported Change in Accured Expenses of $135000.0 for Q1 2026, up 123.4% year-over-year from $60430.6 in Q1 2025, and up 108.99% quarter-over-quarter from -$1.5 million in Q4 2025.
Adagio Medical Holdings (ADGM) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Adagio Medical Holdings (ADGM) has 4 years of Change in Accured Expenses data on file, last reported at $135000.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $135000.0, up 123.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 728.33% YoY), and the FY2025 annual result was $3.3 million, up 2498.43% from the prior year.
- Change in Accured Expenses improved to $135000.0 in Q1 2026 per ADGM's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $963000.0 in Q2 2024 and troughed at -$1.5 million in Q4 2025.
- A 4-year average of -$167142.9 and a median of -$216000.0 in 2023 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses tumbled 185.1% in 2025, then surged 123.4% in 2026.
- A 4-year view of Change in Accured Expenses shows it stood at -$216000.0 in 2023, then slumped by 201.39% to -$651000.0 in 2024, then slumped by 130.72% to -$1.5 million in 2025, then soared by 108.99% to $135000.0 in 2026.
- Business Quant data shows ADGM's Change in Accured Expenses at $135000.0 in Q1 2026, -$1.5 million in Q4 2025, and -$577000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Adagio Medical Holdings | 16.44 Mn | 3.54 Mn | - | 135,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Dec 31, 2025 | -1.50 Mn |
| Dec 31, 2025 | -1.50 Mn |
| Mar 31, 2025 | -577,000.00 |
| Mar 31, 2025 | -577,000.00 |
| Sep 30, 2024 | -651,000.00 |
| Sep 30, 2024 | -651,000.00 |
| Jun 30, 2024 | 963,000.00 |
| Jun 30, 2024 | 963,000.00 |
| Mar 31, 2024 | 678,000.00 |
| Mar 31, 2024 | 678,000.00 |
| Dec 31, 2023 | -216,000.00 |
| Dec 31, 2023 | -216,000.00 |